Tritonix.ai

News / Taiwan / cnyes

Tanvex (4114) August Revenue Climbs Nearly 50% Year-on-Year

Health Technology · Pharmaceuticals: Major · cnyes · 2026-09-08

4114

Tanvex (4114) reported August 2026 revenue of NT$754 million, a 49.88% year-on-year increase, maintaining steady growth momentum for the year.

What Happened

Revenue Performance: Tanvex (4114) announced August 2026 revenue of NT$754 million, showing a 49.88% year-on-year increase, while the monthly growth rate was -4.73%.

Cumulative Results: The cumulative revenue for the first eight months of 2026 reached NT$5.096 billion, reflecting a year-to-date growth rate of 25.5%.

Stock Performance: The stock is currently trading at NT$29.6, with a 0.67% decline over the past five days, underperforming the biotechnology and medical index which rose 1.03%.

Business Profile: Tanvex is engaged in the manufacturing and distribution of various pharmaceuticals, medical devices, cosmetics, veterinary drugs, and food additives.

Read original

More in Health Technology

Xufu August Revenue Soars 187.52% Year-over-Year

Health Technology · cnyes · 2026-09-08

Xufu (4119) reported August 2026 revenue of NT$149 million, a 187.52% year-over-year surge, with year-to-date revenue growth at 14.21%.

4119

AstraZeneca Reports Positive Late-Stage Data for Tozorakimab in COPD Treatment

Health Technology · cnbc · 2026-09-08

AstraZeneca's experimental COPD drug, tozorakimab, showed significant efficacy in late-stage trials, bolstering the company's multi-billion dollar sales outlook.

AZN, AZN, SNY, GSK, GILD, SNY, REGN, GSK, IBB

Taiwan Biotech Firms Joyful: Fortune and PharmaEssentia Report Record August Revenues

Health Technology · economic_daily · 2026-09-08

Taiwanese biotech companies Fortune and PharmaEssentia posted record-breaking August revenues, driven by strong product sales and international market expansion.

Latest in Taiwan

Chang Hwa Bank Reports Record 8-Month Profit Growth of 23.21%

Finance · cnyes · 2026-09-08

Chang Hwa Bank announced an 8-month net profit of NT$15.57 billion, driven by strong lending and wealth management performance, resulting in an EPS of NT$1.29.

2801

Fuchang's August Revenue Hits Second-Highest Monthly Record

Process Industries · economic_daily · 2026-09-08

Fuchang-KY reported August revenue of NT$1.192 billion, marking a 42.4% year-on-year increase, driven by strong seasonal demand and holiday restocking.

8411

Taiwan Mobile Eyes Top Telecom Spot with Potential SYSTEX Acquisition

Technology Services · cnyes · 2026-09-08

Taiwan Mobile CEO Jamie Lin says a successful acquisition of SYSTEX could propel the company's revenue to challenge the industry leader by next year.

2412, 3045, 6214

Junxing-KY Posts Record Eight-Month Revenue, Eyes Robotics Growth

Producer Manufacturing · economic_daily · 2026-09-08

Junxing-KY reported record cumulative revenue of NT$2.125 billion for the first eight months, bolstered by strong demand for robotics and smart transmission.

4571